Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProQuad Vaccination in Pediatric Solid Organ Transplant Candidates
NCT02687763Phase 1Completed
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2015
- Primary completion
- Nov 2016
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of varicella virus vaccine in measles, mumps, rubella and 1 more, sponsored by Medical University of South Carolina. Primary endpoints: Varicella IgG Antibody Titer >= 1.1 IU/ml, Measles IgG Antibody Titer >= 30 AU/ml and 2 more. Started Dec 2015; status: completed.
02
Drugs
varicella virus vaccine
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT02687763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687763.